跳至主要内容
临床试验/ISRCTN26221020
ISRCTN26221020已完成未知

A randomized phase IV clinical trial comparing Nadolol and Isosorbide Mononitrate (ISMN) with the combination of Endoscopic Banding Ligation plus Nadolol and ISMN in the prevention of variceal rebleeding

Individual Sponsor (Spain)0 个研究点目标入组 160 人开始时间: 2006年3月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
160

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age between 18-75
  • 2. Diagnosis of cirrhosis
  • 3. Hematemesis or melena within 7 days prior to inclusion
  • 4. Esophageal or gastroesophageal varices as the source of bleeding
  • 5. Written informed consent
  • 6. Exclusion of pregnancy in woman of child-bearing potential

排除标准

  • 1. Hepatocellular carcinoma >5 cm or multinodular
  • 2.Creatinine >2 mg/dl
  • 3. Child-Pugh =13 points
  • 4. Contraindications to beta-adrenergic blockers
  • 5. Contraindications to ISMN
  • 6. Banding ligation in the 3 months before the present episode of variceal bleeding
  • 7. Previous portosystemic derivative therapy
  • 8. Bleeding from fundal or ectopic varices
  • 9. Total portal vein thrombosis or portal vein cavernomatosis
  • 10. The patient was already on beta-adrenergic blockers and ISMN for the prevention of variceal bleeding

研究者

发起方
Individual Sponsor (Spain)

相似试验